Effects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Huang, Haohai ^a   Chen, Guangzhao ^b   Liao, Dan ^c   Zhu, Yongkun ^a   Xue, Xiaoyan ^a  

^a Affiliated Dongguan Shilong People's Hospital of Southern Medical University   (China)

^b Central Hospital of Guangdong Provincial Agricultural Reclamation   (China)

^c Dongguan Maternal and Child Health Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHEMISTRY; DIET THERAPY; FEMALE; FRUIT; HUMAN; MALE; META ANALYSIS; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; YOUNG ADULT;

ADULT; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FEMALE; FRUIT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84962265096     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23625     Document Type: Article

References (60)

1. World Health Organization Statistics 2013. Cardiovascular diseases. Available at: Http://www.who.int/mediacentre/factsheets/fs317/en/index. html. (Accessed: 27 February 2014).
2. Smith, S. C. Jr. et al. Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation 126, 2769-2775, doi: 10.1161/CIR.0b013e318267e99f (2012).
3. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364, 937-952, doi: 10.1016/s0140-6736(04)17018-9 (2004).
4. Jain, K. S., Kathiravan, M. K., Somani, R. S. & Shishoo, C. J. The biology and chemistry of hyperlipidemia. Bioorg Med Chem 15, 4674-4699, doi: 10.1016/j.bmc.2007.04.031 (2007).
5. Lloyd-Jones, D. et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121, e46-e215, doi: 10.1161/circulationaha.109.192667 (2010).
6. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (2002).
7. Banach, M. & Aronow, W. S. Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens 26, 641-643, doi: 10.1038/jhh.2012.3 (2012).
8. Chen, Z. Y., Jiao, R. & Ma, K. Y. Cholesterol-lowering nutraceuticals and functional foods. J Agric Food Chem 56, 8761-8773, doi: 10.1021/jf801566r (2008).
9. Serban, C., Sahebkar, A., Ursoniu, S., Andrica, F. & Banach, M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. J Hypertens 33, 1119-1127, doi: 10.1097/hjh.0000000000000585 (2015).
10. Serban, M. C. et al. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr, doi: 10.1016/j.clnu.2015.09.007 (2015).
11. Talati, R., Baker, W. L., Pabilonia, M. S., White, C. M. & Coleman, C. I. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 7, 157-163, doi: 10.1370/afm.917 (2009).
12. Maatta-Riihinen, K. R., Kamal-Eldin, A., Mattila, P. H., Gonzalez-Paramas, A. M. & Torronen, A. R. Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52, 4477-4486, doi: 10.1021/jf049595y (2004).
13. Milbury, P. E., Vita, J. A. & Blumberg, J. B. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr 140, 1099-1104, doi: 10.3945/jn.109.117168 (2010).
14. Ruel, G. & Couillard, C. Evidences of the cardioprotective potential of fruits: The case of cranberries. Mol Nutr Food Res 51, 692-701, doi: 10.1002/mnfr.200600286 (2007).
15. Valentova, K. et al. Biosafety, antioxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: A pilot double-blind placebo-controlled trial. J Agric Food Chem 55, 3217-3224, doi: 10.1021/jf0636014 (2007).
16. Zhu, Y. et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial. Nutr Metab Cardiovasc Dis 23, 843-849, doi: 10.1016/j.numecd.2012.06.005 (2013).
17. Zhu, Y. et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem 57, 1524-1533, doi: 10.1373/clinchem.2011.167361 (2011).
18. Duthie, S. J. et al. The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur J Nutr 45, 113-122, doi: 10.1007/s00394-005-0572-9 (2006).
19. Karlsen, A. et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of proinflammatory mediators in healthy adults. J Nutr 137, 1951-1954 (2007).
20. Wang, C. et al. Cardiovascular disease prevention of cranberry vinegar. Nutr Sci 32, No. 4, 129-132 (2007).
21. Lee, I. T., Chan, Y. C., Lin, C. W., Lee, W. J. & Sheu, W. H. Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Diabet Med 25, 1473-1477, doi: 10.1111/j.1464-5491.2008.02588.x (2008).
22. Erlund, I. et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 87, 323-331 (2008).
23. Qin, Y. et al. Anthocyanin supplementation improves serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr 90, 485-492, doi: 10.3945/ajcn.2009.27814 (2009).
24. Curtis, P. J. et al. Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr 139, 2266-2271, doi: 10.3945/jn.109.113126 (2009).
25. Stull, A. J., Cash, K. C., Johnson, W. D., Champagne, C. M. & Cefalu, W. T. Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr 140, 1764-1768, doi: 10.3945/jn.110.125336 (2010).
26. Basu, A. et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140, 1582-1587, doi: 10.3945/jn.110.124701 (2010).
27. Basu, A. et al. Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 31, 190-196, doi: 10.1016/j.nutres.2011.02.003 (2011).
28. Dohadwala, M. M. et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 93, 934-940, doi: 10.3945/ajcn.110.004242 (2011).
29. Flammer, A. J. et al. Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells. Eur J Nutr 52, 289-296, doi: 10.1007/s00394-012-0334-4 (2013).
30. Riso, P. et al. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr 52, 949-961, doi: 10.1007/s00394-012-0402-9 (2013).
31. Murkovic, M. et al. Effects of elderberry juice on fasting and postprandial serum lipids and low-density lipoprotein oxidation in healthy volunteers: A randomized, double-blind, placebo-controlled study. Eur J Clin Nutr 58, 244-249, doi: 10.1038/sj.ejcn.1601773 (2004).
32. Novotny, J. A., Baer, D. J., Khoo, C., Gebauer, S. K. & Charron, C. S. Cranberry juice consumption lowers markers of cardiometabolic risk, including blood pressure and circulating C-reactive protein, triglyceride, and glucose concentrations in adults. J Nutr 145, 1185-1193, doi: 10.3945/jn.114.203190 (2015).
33. Kianbakht, S., Abasi, B. & Hashem Dabaghian, F. Improved lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydroalcoholic extract: A randomized double-blind placebo-controlled clinical trial. Phytother Res 28, 432-436, doi: 10.1002/ptr.5011 (2014).
34. Soltani, R. et al. Evaluation of the Effects of Vaccinium arctostaphylos L. Fruit Extract on Serum Lipids and hs-CRP Levels and Oxidative Stress in Adult Patients with Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Evid Based Complement Alternat Med 2014, 217451, doi: 10.1155/2014/217451 (2014).
35. Li, D., Zhang, Y., Liu, Y., Sun, R. & Xia, M. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr 145, 742-748, doi: 10.3945/jn.114.205674 (2015).
36. Jeong, H. S. et al. Effects of black raspberry on lipid profiles and vascular endothelial function in patients with metabolic syndrome. Phytother Res 28, 1492-1498, doi: 10.1002/ptr.5154 (2014).
37. Zhu, Y. et al. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J Clin Endocrinol Metab 99, 561-569, doi: 10.1210/jc.2013-2845 (2014).
38. Youdim, K. A., McDonald, J., Kalt, W. & Joseph, J. A. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults ( small star, filled). J Nutr Biochem 13, 282-288 (2002).
39. Xia, M. et al. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: The role of the peroxisome proliferatoractivated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J Biol Chem 280, 36792-36801, doi: 10.1074/jbc.M505047200 (2005).
40. Lamy, S. et al. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 29, 1033-1041, doi: 10.1093/carcin/bgn070 (2008).
41. Miyazaki, K., Makino, K., Iwadate, E., Deguchi, Y. & Ishikawa, F. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice. J Agric Food Chem 56, 11485-11492, doi: 10.1021/jf801876n (2008).
42. Wang, D., Wei, X., Yan, X., Jin, T. & Ling, W. Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem 58, 12722-12728, doi: 10.1021/jf103427j (2010).
43. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285, 2486-2497 (2001).
44. Hobbs, F. D., Banach, M., Mikhailidis, D. P., Malhotra, A. & Capewell, S. Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate. BMC Med 14, 4, doi: 10.1186/s12916-016-0550-5 (2016).
45. Baigent, C. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376, 1670-1681, doi: 10.1016/s0140-6736(10)61350-5 (2010).
46. Hausenloy, D. J. & Yellon, D. M. Targeting residual cardiovascular risk: Raising high-density lipoprotein cholesterol levels. Heart 94, 706-714, doi: 10.1136/hrt.2007.125401 (2008).
47. Banach, M. et al. Lipids, blood pressure and kidney update 2015. Lipids Health Dis 14, 167, doi: 10.1186/s12944-015-0169-0 (2015).
48. Gordon, D. J. et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8-15 (1989).
49. Herder, C., Karakas, M. & Koenig, W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 90, 52-66, doi: 10.1038/clpt.2011.93 (2011).
50. Greenland, P. et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122, e584-636, doi: 10.1161/CIR.0b013e3182051b4c (2010).
51. Ridker, P. M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363-369 (2003).
52. Chen, W. et al. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol 674, 359-364, doi: 10.1016/j.ejphar.2011.10.040 (2012).
53. Higgins, J. P. et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343, d5928, doi: 10.1136/bmj.d5928 (2011).
54. Montedori, A. et al. Modified versus standard intention-to-treat reporting: Are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. Trials 12, 58, doi: 10.1186/1745-6215-12-58 (2011).
55. Higgins J. P. & Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). Available at: Http://handbook.cochrane.org/. (Accessed: 12 September 2011)
56. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557-560, doi: 10.1136/bmj.327.7414.557 (2003).
57. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).
58. Brok, J., Thorlund, K., Wetterslev, J. & Gluud, C. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol 38, 287-298, doi: 10.1093/ije/dyn188 (2009).
59. Wetterslev, J., Thorlund, K., Brok, J. & Gluud, C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Int J Epidemiol 61, 64-75, doi: 10.1016/j.jclinepi.2007.03.013 (2008).
60. Wetterslev, J., Thorlund, K., Brok, J. & Gluud, C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9, 86, doi: 10.1186/1471-2288-9-86 (2009).